Table of Content

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Animal Type
1.1.2 Product
1.1.3 Distribution Channel
1.1.4 End Use
1.1.5 Etimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 U.S. Companion Animal Health Market Outlook, 2017-2030 (USD Million)
2.2 Segment Outlook
2.3 Competitive Outlook
Chapter 3 U.S. Companion Animal Health Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.1.1.1 Global Companion Animal Health Market Outlook, 2017-2030 (USD Million)
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis
3.4 Industry Value Chain Analysis
3.4.1 Cost Structure Analysis
3.4.1.1 Investments in the U.S. Companion Animal Health
3.4.2 Distribution channel analysis
3.4.3 User perspective analysis
3.4.3.1 Consumer Behavior Analysis
3.4.3.2 Pet Animal Owner Profiles
3.4.3.3 Market Influencer Analysis
3.5 Technology Overview
3.5.1 Technology Timeline Veterinary orthopedics changing technology & adoption
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards & Compliances in the U.S.
3.7 U.S. Companion Animal Health Market dynamics
3.7.1 Market driver analysis
3.7.1.1 Rising number of companion ownership
3.7.1.2 Increase in number of government initiatives
3.7.1.3 Increasing prevalence of zoonotic diseases
3.7.2 Market restraint analysis
3.7.2.1 Increase in advent of counterfit Drugs
3.7.3 Industry Challenges
3.7.3.1 Short product exclusivity
3.8 U.S. Companion Animal Health Market Analysis Tools
3.8.1 Industry Analysis: Poter’s
3.8.1.1 Supplier Power
3.8.1.2 Buyer Power
3.8.1.3 Threat Of Substitutes
3.8.1.4 Threat Of New Entrants
3.8.1.5 Competitive Rivalry
3.8.2 SWOT analysis, by factor (political & legal, economic and technological)
3.8.2.1 Political Landscape
3.8.2.2 Economic Landscape
3.8.2.3 Social Landscape
3.8.2.4 Technology Landscape
3.8.2.5 Legal Landscape
3.8.3 Major Deals & Strategic Alliances Analysis
3.8.3.1 Joint Ventures
3.8.3.2 Mergers & Acquisitions
3.8.3.3 Licensing & Partnership
3.8.3.4 Technology Collaborations
3.8.4 Market Entry Strategies
3.9 U.S. Companion Animal Health Market: Covid-19 Impact Analysis
Chapter 4 U.S. Companion Animal Health Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Market Participation Categorization
4.1.1.1 Market Leader
4.1.1.2 Innovators
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key Customers
4.3 Opportunity Analysis
4.3.1 U.S. Companion Animal Health: Company Market Share Analysis
4.3.2 Public Companies
4.3.2.1 Competitive dashboard analysis
4.3.2.2 Company market position analysis
4.3.3 Private Companies
4.3.3.1 List of key emerging companies
Chapter 5 U.S. Companion Animal Health Market: Animal Type Estimates & Trend Analysis
5.1 Animal Type Market Share Analysis, 2021 & 2030
5.2 Animal Type Dashboard
5.3 U.S. Companion Animal Health Market, by Animal Type, 2017 to 2030
5.4 Dogs
5.4.1 Dogs market estimates and forecasts, 2017 - 2030 (USD Million)
5.5 Equine
5.5.1 Equine market estimates and forecasts, 2017 - 2030 (USD Million)
5.6 Cats
5.6.1 cats market estimates and forecasts, 2017 - 2030 (USD Million)
5.7 Sheep & Goats
5.7.1 Sheep & Goats market estimates and forecasts, 2017 - 2030 (USD Million)
5.8 Companion Poultry
5.8.1 Companion Poultry market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 6 U.S. Companion Animal Health Market: Product Estimates & Trend Analysis
6.1 Product Market Share Analysis, 2021 & 2030
6.2 Product Dashboard
6.3 U.S. Companion Animal Health Market, by Product, 2017 to 2030
6.4 Vaccines
6.4.1 Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
6.5 Pharmaceuticals
6.5.1 Pharmaceuticals market estimates and forecasts, 2017 - 2030 (USD Million)
6.5.2 OTC
6.5.2.1 OTC drugs market estimates and forecasts, 2017 - 2030 (USD Million)
6.5.3 prescription
6.5.3.1 prescription drugs market estimates and forecasts, 2017 - 2030 (USD Million)
6.6 Feed Additives
6.6.1 Feed additives market estimates and forecasts, 2017 - 2030 (USD Million)
6.7 Diagnostics
6.7.1 Diagnostics market estimates and forecasts, 2017 - 2030 (USD Million)
6.8 Others
6.8.1 Other U.S. Companion Animal Health Products market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 7 U.S. Companion Animal Health Market: Distribution Channel Estimates & Trend Analysis
7.1 Distribution Channel Market Share Analysis, 2021 & 2030
7.2 Distribution Channel Dashboard
7.3 U.S. Companion Animal Health Market by Distribution Channel 2017 to 2030
7.3.1 Retail
7.3.2 retail market estimates and forecasts, 2017 - 2030 (USD Million)
7.4 E-commerce
7.4.1 e-commerce market estimates and forecasts, 2017 - 2030 (USD Million)
7.5 Hospital Pharmacy
7.5.1 Hospital pharmacy market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 8 U.S. Companion Animal Health Market: End-use Estimates & Trend Analysis
8.1 End-use Market Share Analysis, 2021 & 2030
8.2 End-use Dashboard
8.3 U.S. Companion Animal Health Market by End-use, 2017 to 2030
8.4 Point-of-care/In-house Testing
8.4.1 Point-of-care/In-house Testing market estimates and forecasts, 2017 - 2030 (USD Million)
8.5 Veterinary Hospitals & Clinics
8.5.1 Veterinary hospitals & clinics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6 Others
8.6.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
9.1 Merck Animal Health
9.1.1 Company overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Ceva Sant? Animale
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 Vetiquinol S.A.
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 Zoetis
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Boehringer Ingelheim GmbH
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Bayer AG
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Elanco
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Virbac, Inc.
9.8.1 Company overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Norbrook Inc.
9.9.1 Company overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 Dechra Pharmaceuticals
9.10.1 Company overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives
9.11 Patterson Companies, Inc.
9.11.1 Company overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives
9.12 Vedco Inc.
9.12.1 Company overview
9.12.2 Financial Performance
9.12.3 Product Benchmarking
9.12.4 Strategic Initiatives
9.13 MWI Animal Health
9.13.1 Company overview
9.13.2 Financial Performance
9.13.3 Product Benchmarking
9.13.4 Strategic Initiatives
9.14 Covetrus
9.14.1 Company overview
9.14.2 Financial Performance
9.14.3 Product Benchmarking
9.14.4 Strategic Initiatives
9.15 Ellevet Sciences
9.15.1 Company overview
9.15.2 Financial Performance
9.15.3 Product Benchmarking
9.15.4 Strategic Initiatives



List of Figures

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 U.S. companion animal health market revenue, 2017 - 2030 (USD Million)
Fig. 11 U.S. Companion animal health market snapshot
Fig. 12 Companion animal health market revenue, 2017 - 2030 (USD Million)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Drug development process for companion animal segment
Fig. 15 Companion animal health: Market influencing factors
Fig. 16 Companion animal health: Market dynamics
Fig. 17 U.S. companion animal health market dynamics
Fig. 18 U.S. Companion Animal Health market driver impact
Fig. 19 U.S. Pet ownership statistics by animal type
Fig. 20 U.S. Pet ownership statistics till 2021
Fig. 21 U.S. Companion Animal Health market restraint impact
Fig. 22 U.S. Companion Animal Health market: Porter’s five forces analysis
Fig. 23 SWOT Analysis, By Factor (Political & legal, economic and technological)
Fig. 24 Market entry strategies
Fig. 25 Market participant categorization
Fig. 26 Company Market Share Analysis, 2021 (%)
Fig. 27 Competitive dashboard analysis
Fig. 28 Company market position analysis
Fig. 29 U.S. companion animal health market: Animal type movement analysis
Fig. 30 U.S. companion animal health market animal type dashboard
Fig. 31 U.S. companion animal health market by animal type
Fig. 32 U.S. dogs market, 2017 - 2030 (USD Million)
Fig. 33 U.S. Equine market, 2017 - 2030 (USD Million)
Fig. 34 U.S. cats market, 2017 - 2030 (USD Million)
Fig. 35 U.S. sheep & goats market, 2017 - 2030 (USD Million)
Fig. 36 U.S. companion poultry market, 2017 - 2030 (USD Million)
Fig. 37 U.S. companion animal health market: Product movement analysis
Fig. 38 U.S. companion animal health product dashboard
Fig. 39 U.S. companion animal health Market, by Product, 2017 to 2030
Fig. 40 U.S. vaccines market, 2017 - 2030 (USD Million)
Fig. 41 U.S. pharmaceuticals market, 2017 - 2030 (USD Million)
Fig. 42 U.S. OTC drugs market, 2017 - 2030 (USD Million)
Fig. 43 U.S. prescription drugs market, 2017 - 2030 (USD Million)
Fig. 44 U.S. feed additives market, 2017 - 2030 (USD Million)
Fig. 45 U.S. diagnostics market, 2017 - 2030 (USD Million)
Fig. 46 U.S. others market, 2017 - 2030 (USD Million)
Fig. 47 U.S. companion animal health market: Distribution channel movement analysis
Fig. 48 U.S. companion animal health market distribution channel dashboard
Fig. 49 U.S. Companion Animal Health Market by Distribution Channel 2017 to 2030
Fig. 50 U.S. retail market, 2017 - 2030 (USD Million
Fig. 51 U.S. e-commerce market, 2017 - 2030 (USD Million
Fig. 52 U.S. hospital pharmacy market, 2017 - 2030 (USD Million)
Fig. 53 U.S. companion animal health market: End-use movement analysis
Fig. 54 U.S. companion animal health market End-use dashboard
Fig. 55 U.S. companion animal health Market by End-use, 2017 to 2030
Fig. 56 U.S. point-of-care/in-house testing market, 2017 - 2030 (USD Million)
Fig. 57 U.S. veterinary hospitals & clinics market, 2017 - 2030 (USD Million)
Fig. 58 U.S. others market, 2017 - 2030 (USD Million)

List of Tables

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Products in pipeline
Table 4 Deals & strategic alliances in U.S. Companion Animal Health
Table 5 List of Distributors
Table 6 List of key emerging companies